European life sciences investor Medicxi has raised 500 million euros (about $581.6 million) to go directly toward innovative ...

Launched its first Asia office to support biotech and healthtech innovation and collaboration within the regionThe Asia ...

The European venture firm raised 500 million euros, or about $579 million, for its latest fund, which follows a flurry of ...

Repligen (RGEN) is a top bioprocessing stock pick for long-term investors. It has strong balance sheet and recurring organic ...

The EU Biotech Act was first spoken about in EC President Ursula von der Leyen's political guidelines for 2025 in July 2024.

Explore the Wasatch U.S. Select Fund's Q3 2025 results, including underperformance vs. its benchmark and analysis of key ...

Medicxi, a leading European life sciences venture capital firm, today announced the closing of Medicxi V, a €500 million fund dedicated to building and backing innovative biotechnology companies with ...

Regeneron Pharmaceuticals, a global biotech company founded in New York City, is more than doubling its manufacturing ...

Biotech stocks have performed well this year. The SPDR S&P Biotech ETF -- an industry benchmark -- is up 21% this year. Two ...

The National Seed Trade Association of Ghana (NASTAG) has called for an urgent review of the country’s 2013 Seed Policy to ...

Governor Kathy Hochul announced Thursday that Regeneron Pharmaceuticals, a global leader in biotechnology founded in New York State, will create 1,000 new jobs ...

Monash University spinout RAGE Biotech has raised $29 million in Series A funding, marking a major step toward translating ...